Why MBIO? Mustang Bio, Inc. Analysis, Price & AI Insights | Whystock
MBIO
$0.75+0.01 (+1.81%)
Market ClosedLast close May 1
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States.